Oral Health CRC: Ledger

Stories naming Oral Health CRC. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Oral Health CRC is not recorded as having acquired anything.

Name	Role	Sources
Professor Eric Reynolds AO	CEO · Founder	Brandon BioCatalyst portfolio, Brandon Capital portfolio

Series A $14m

$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease

A biotech spin-out from the University of Melbourne has raised a Series A to develop a gum disease vaccine, backed by a biomedical translation fund, a large biotech company and the university itself.

Brandon Capital portfolio Thu 26 Sep 2019 Denteric Brandon Capital Partners Centre for Oral Health Research (COHR)Cooperative Research Centres Program Medical Research Commercialisation Fund (MRCF)Melbourne Dental School Oral Health CRC Victorian Government Australian Government Biomedical Translation Fund CSL University of Melbourne Dr Andrew Nash Dr Chris Nave Professor Eric Reynolds AO Professor Jim McCluskey

Also Brandon BioCatalyst portfolio·Startup Daily·denteric.com·denteric.com·@AuManufacturing·Startup Daily

Oral Health CRC

Funding history

Investors

What Oral Health CRC bought

People

Coverage

$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease